R. Vassar et al., beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE, SCIENCE, 286(5440), 1999, pp. 735-741
Cerebral deposition of amyloid beta peptide (A beta) is an early and critic
al feature of Alzheimer's disease. A beta generation depends on proteolytic
cleavage of the amyloid precursor protein (APP) by two unknown proteases:
beta-secretase and gamma-secretase. These proteases are prime therapeutic t
argets. A transmembrane aspartic protease with all the known characteristic
s of beta-secretase was cloned and characterized. Overexpression of this pr
otease, termed BACE (for beta-site APP-cleaving enzyme) increased the amoun
t of beta-secretase cleavage products, and these were cleaved exactly and o
nly at known beta-secretase positions. Antisense inhibition of endogenous B
ACE messenger RNA decreased the amount of beta-secretase cleavage products,
and purified BACE protein cleaved APP-derived substrates with the same seq
uence specificity as beta-secretase. Finally, the expression pattern and su
bcellular Localization of BACE were consistent with that expected for beta-
secretase. Future development of BACE inhibitors may prove beneficial for t
he treatment of Alzheimer's disease.